Related references
Note: Only part of the references are listed.Structural and functional analysis of target recognition by the lymphocyte adaptor protein LNK
Rhiannon Morris et al.
NATURE COMMUNICATIONS (2021)
Highly accurate protein structure prediction with AlphaFold
John Jumper et al.
NATURE (2021)
Monogenic and polygenic inheritance become instruments for clonal selection
Po-Ru Loh et al.
NATURE (2020)
The BRISC deubiquitinating enzyme complex limits hematopoietic stem cell expansion by regulating JAK2 K63-ubiquitination
Ryan Donaghy et al.
BLOOD (2019)
Evidence for a Causal Role of the SH2B3-2M Axis in Blood Pressure Regulation: Framingham Heart Study
Joshua A. Keefe et al.
HYPERTENSION (2019)
SH2B3 inactivation through CN-LOH 12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain
Paul B. Sinclair et al.
LEUKEMIA (2019)
Germline SH2B3 pathogenic variant associated with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis
Giacomo Coltro et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
LNK suppresses interferon signaling in melanoma
Ling-Wen Ding et al.
NATURE COMMUNICATIONS (2019)
Essential Thrombocythemia
Ayalew Tefferi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Lnk/Sh2b3 deficiency restores hematopoietic stem cell function and genome integrity in Fancd2 deficient Fanconi anemia
Joanna Balcerek et al.
NATURE COMMUNICATIONS (2018)
Role of SH2B3 R262W gene polymorphism and risk of coronary heart disease A PRISMA-compliant meta-analysis
Lu Hong et al.
MEDICINE (2018)
CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies
Kaosheng Lv et al.
GENES & DEVELOPMENT (2017)
The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders
N. Maslah et al.
LEUKEMIA (2017)
LNK mutations and myeloproliferative disorders
Mary Frances McMullin et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Targeted Application of Human Genetic Variation Can Improve Red Blood Cell Production from Stem Cells
Felix C. Giani et al.
CELL STEM CELL (2016)
Linking inflammation and hypertension via LNK/SH2B3
Bethany L. Dale et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2016)
Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations
Carme Camps et al.
HAEMATOLOGICA (2016)
LNK/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitors
Ying Cheng et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
The Polymorphisms in LNK Gene Correlated to the Clinical Type of Myeloproliferative Neoplasms
Yan Chen et al.
PLOS ONE (2016)
Molecular characterisation of triple negative essential thrombocythaemia patients by platelet analysis and targeted sequencing
A. Angona et al.
BLOOD CANCER JOURNAL (2016)
Co-existence of IL7R high and SH2B3 low expression distinguishes a novel high-risk acute lymphoblastic leukemia with Ikaros dysfunction
Zheng Ge et al.
ONCOTARGET (2016)
Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations
Carme Camps et al.
HAEMATOLOGICA (2016)
MERIT40 deficiency expands hematopoietic stem cell pools by regulating thrombopoietin receptor signaling
Krasimira Rozenova et al.
BLOOD (2015)
Cooperative Genetic Changes in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia with Deletions or Mutations of IKZF1
Linda Olsson et al.
GENES CHROMOSOMES & CANCER (2015)
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
K. G. Roberts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Genetic loss of SH2B3 in acute lymphoblastic leukemia
Arianne Perez-Garcia et al.
BLOOD (2013)
SH2B3 (LNK) mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F
Maya Koren-Michowitz et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Infrequent occurrence of mutations in the PH domain of LNK in patients with JAK2 mutation-negative 'idiopathic' erythrocytosis
A. Spolverini et al.
HAEMATOLOGICA (2013)
Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
Thorsten Klampfl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The Lnk Adaptor Protein: A Key Regulator of Normal and Pathological Hematopoiesis
Laura Velazquez
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2012)
Adaptor protein Lnk binds to and inhibits normal and leukemic FLT3
De-Chen Lin et al.
BLOOD (2012)
Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia
Kathryn G. Roberts et al.
CANCER CELL (2012)
14-3-3 regulates the LNK/JAK2 pathway in mouse hematopoietic stem and progenitor cells
Jing Jiang et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Jinghui Zhang et al.
NATURE (2012)
A nonsynonymous LNK polymorphism associated with idiopathic erythrocytosis
Mary Frances McMullin et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Adaptor protein Lnk binds to PDGF receptor and inhibits PDGF-dependent signaling
Saskia Gueller et al.
EXPERIMENTAL HEMATOLOGY (2011)
x Clonal hierarchy and allelic mutation segregation in a myelofibrosis patient with two distinct LNK mutations
T. L. Lasho et al.
LEUKEMIA (2011)
Octa-Arginine Mediated Delivery of Wild-Type Lnk Protein Inhibits TPO-Induced M-MOK Megakaryoblastic Leukemic Cell Growth by Promoting Apoptosis
Chung Yeng Looi et al.
PLOS ONE (2011)
The Adaptor Protein SH2B3 (Lnk) Negatively Regulates Neurite Outgrowth of PC12 Cells and Cortical Neurons
Tien-Cheng Wang et al.
PLOS ONE (2011)
Management of Myelofibrosis
Alessandro M. Vannucchi
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2011)
Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms
Stephen T. Oh et al.
BLOOD (2010)
Expression level and differential JAK2-V617F-binding of the adaptor protein Lnk regulates JAK2-mediated signals in myeloproliferative neoplasms
Fanny Baran-Marszak et al.
BLOOD (2010)
The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis
A. Alcina et al.
GENES AND IMMUNITY (2010)
Adaptor protein Lnk inhibits c-Fms-mediated macrophage function
Saskia Gueller et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations
A. Pardanani et al.
LEUKEMIA (2010)
Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
A. Tefferi
LEUKEMIA (2010)
Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F
Sigal Gery et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Adaptor protein Lnk associates with Tyr568 in c-Kit
Saskia Gueller et al.
BIOCHEMICAL JOURNAL (2008)
Link controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2
Alexey Bersenev et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Phosphorylation of human Jak3 at tyrosines 904 and 939 positively regulates its activity
Hanyin Cheng et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Adaptor protein Lnk negatively regulates the mutant MPL, MPLW515L associated with myeloproliferative disorders
Sigal Gery et al.
BLOOD (2007)
Lnk negatively regulates self-renewal of hematopoietic stem cells by modifying thrombopoietin-mediated signal transduction
Jun Seita et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
MPL515 mutations in myeloproliferative and other myeloid disorders:: a study of 1182 patients
Animesh D. Pardanani et al.
BLOOD (2006)
Structural basis for phosphotyrosine recognition by the Src homology-2 domains of the adapter proteins SH2-B and APS
Junjie Hu et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
The adaptor molecule Lnk negatively regulates tumor necrosis factor-α-dependent VCAM-1 expression in endothelial cells through inhibition of the ERK1 and -2 pathways
Juliette Fitau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Enhanced engraftment of hematopoietic stem/progenitor cells by the transient inhibition of an adaptor protein, Lnk
H Takizawa et al.
BLOOD (2006)
The V617F JAK2 mutation is uncommon in cancers and in myeloid malignancies other than the classic myeloproliferative disorders
LM Scott et al.
BLOOD (2005)
Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders
AV Jones et al.
BLOOD (2005)
Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways
W Tong et al.
BLOOD (2005)
Suppressor screen in Mpl-/- mice:: c-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling
MR Carpinelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A phenylalanine zipper mediates APS dimerization
D Dhe-Sirano et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis
W Tong et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Structural basis for recruitment of the adaptor protein APS to the activated insulin receptor
JJ Hu et al.
MOLECULAR CELL (2003)
Impaired lymphopoiesis and altered B cell subpopulations in mice overexpressing Lnk adaptor protein
S Takaki et al.
JOURNAL OF IMMUNOLOGY (2003)
Cytokine signaling and hematopoietic homeostasis are disrupted in Lnk-deficient mice
L Velazquez et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Cloning and characterization of human Lnk, an adaptor protein with pleckstrin homology and Src homology 2 domains that can inhibit T cell activation
YJ Li et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
